Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FOXF2 antisense RNA 1 (FOXF2-AS1) is a long non-coding RNA transcribed on the opposite strand of the FOXF2 gene locus. Like other antisense RNAs, it can bind to the complementary mRNA (in this case, FOXF2 mRNA) and modulate its stability, splicing, or translation, often resulting in regulatory effects on the expression of FOXF2 or nearby genes. Antisense RNAs are known to regulate gene expression and are increasingly recognized for their roles in cancer biology and cell proliferation. The exact biological and pathological functions of FOXF2-AS1 are not fully understood, but analogous molecules are implicated in controlling cellular processes central to tumor progression and vascular function. If more information is needed regarding its mechanistic roles, disease relevance, or molecular interactions, further dedicated studies specific to FOXF2-AS1 (rather than the FOXF2 gene itself) would be required.
Not applicable; since no drugs directly interact with FOXF2-AS1, mechanisms are not characterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FOXF2 antisense RNA 1 (FOXF2-AS1).